|
10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)- Suppliers list
|
| Company Name: |
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
|
| Tel: |
17702719238 |
| Email: |
sales@sun-shinechem.com |
| Products Intro: |
Product Name:Zurletrectinib CAS:2403703-30-8 Purity:98% HPLC Package:50.0mg;100.0mg; 200.0mg;500mg;1g;5g; 10g
|
| Company Name: |
Shanghai Tube Pharmaceutical Co., Ltd.
|
| Tel: |
021-54338626 18017892860 |
| Email: |
sales@tubepharm.com |
| Products Intro: |
Product Name:Zurletrectinib CAS:2403703-30-8 Purity:98% Package:1kg,10kg,25kg,100kg
|
|
| | 10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)- Basic information |
| Product Name: | 10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)- | | Synonyms: | 10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)-;Zurletrectinib/ICP-723;zurletrectinib;(2S,14S,19bR)-2,18-Difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-10H-5,7-ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one (ACI) | | CAS: | 2403703-30-8 | | MF: | C19H19F2N7O2 | | MW: | 415.4 | | EINECS: | | | Product Categories: | | | Mol File: | 2403703-30-8.mol | ![10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)- Structure](CAS/20240320/GIF/2403703-30-8.gif) |
| | 10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)- Chemical Properties |
| density | 1.66±0.1 g/cm3(Predicted) | | pka | 8.29±0.60(Predicted) |
| | 10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)- Usage And Synthesis |
| Uses | Zurletrectinib is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of preventing TRK-mediated related diseases, such as tumors[1][2]. | | References | [1] Kong NX, et al. Preparation of the heterocyclic compounds as trk inhibitor: World Intellectual Property Organization, WO2020001415. 2020-01-02. [2] WHO Drug Information-World Health Organization (WHO). |
| | 10H-5,7-Ethenopyrazolo[4,3-g]pyrido[3,2-m]pyrrolo[1,2-k][1,4,6,9,11]oxatetraazacyclotetradecin-11(12H)-one, 2,18-difluoro-1,2,3,13,14,19b-hexahydro-14-methyl-, (2S,14S,19bR)- Preparation Products And Raw materials |
|